Skip to main content
Premium Trial:

Request an Annual Quote

Preconception Genetic Testing Firm GenePeeks Secures $3M Loan

NEW YORK (GenomeWeb) – Horizon Technology Finance said this week that it closed a $3 million loan to preconception genetic testing firm GenePeeks.

GenePeeks has offices in New York City and Cambridge, Mass., and focuses on identifying inherited disease risk in future generations. According to Horizon, the firm uses algorithms to simulate the genetic interactions between two potential parents that occur in reproduction, digitally crating and analyzing thousands of hypothetical genomes to discover disease risk that cannot be uncovered by existing pre-pregnancy screening tools.

GenePeeks' initial focus is on the sperm donor industry. In late May, the company launched its sperm donor screening service called Matchright with two partner sperm banks, as Clinical Sequencing News reported at the time. The service combines sequence data from potential sperm donors with sequence data from a female customer to create virtual gametes and then hundreds of thousands of virtual progeny, each with their own virtual genotype. Based on whether any of the genotypes could confer a disease phenotype, donors are ruled in or out, creating a low-risk catalogue for customers of the service.

In late 2012, GenePeeks raised $3 million in a Series A financing round.

"The growth capital with attractive terms provided by Horizon helps to unlock our potential for impact at a very important stage for the company," GenePeeks CEO Anne Morriss said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.